Dr Subodh Kumar Mishra
Research Scientist
New York
Expertise:
Biology
24
Publications
1
Projects
800
Scopus Citations
817
CrossRef
7 Years 6 Months Total Experience
Scopus
800
Citations
18
h-index
CrossRef
817
Citations
17
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
NET Lectureship/Assistant Professor, Life Sciences
2013
Joint CSIR–UGC
Junior Research Fellowship (JRF
2014
Council of Scientific and Industrial Research–University Grants Commission, India | 2014–2017
Senior Research Fellowship (SRF
2017
Council of Scientific and Industrial Research–University Grants Commission, India | 2017–2018
Two Year MDF Postdoctoral Fellowship (2021-2022
2021
Myotonic Dystrophy Foundation, CA, USA
MDA Development Grant (2024–2027) — a transferable award and help transition toward independent research lab
2024
Muscular Dystrophy Association, USA
Community & Membership
Department of Bioscience and Biomedical Engineering, IIT Indore, 2014–2017
Graduate Student RepresentativeComputational Genomics, Frontiers, 2022–Present
Guest Associate EditorTranslational Virology, Frontiers, 2025–Present
Guest Associate EditorNo Data Found
There is currently nothing to display here.
Personal Details
Doctor of Philosophy
2019
Indian Institute of Technology, Mandi
Master of Science
2011
N/A
Bachelor of Science
2009
N/A
Research Scientist
Mar 2022 – Present
Unknown Organization
Post-Doctoral Research Associate
Mar 2019 – Mar 2022
Unknown Organization
Biological Sciences
Scholarly Work
The mechanism, synergies, and therapeutic horizon of quercetin in DM and C9-ALS
OtherNo Data Found
There is currently nothing to display here.
Synergistic Rescue of Myotonic Dystrophy Type 1 Molecular Features by the Combination Treatment of Antisense Oligonucleotides and HDAC Inhibitor
John D. Cleary
J. Andrew Berglund
Kaalak Reddy
Porama Hoque
and Subodh K. Mishra
-
Patent No. :
63/898,888
Filed :
14-10-2025
Published :
30-11--0001
Filed
Combination Therapeutic Approaches for Myotonic Dystrophy and Related Diseases Using Flavonoids and Histone Deacetylase (HDAC) Inhibitors
Andrew J. Berglund
Subodh Kumar Mishra
John Douglas Cleary
Kaalak Reddy
-
Patent No. :
63/708,580
Filed :
14-10-2024
Published :
30-11--0001
Filed
Scholarly Publications
Rationally designed small molecules targeting toxic CAG repeat RNA that causes Huntington's disease (HD) and spinocerebellar ataxia (SCAs)
G-quadruplex stabilization in the ions and maltose transporters inhibit Salmonella enterica growth and virulence
10.1101/357046
Crossref: 1
Generation and application of DNA aptamers against HspX for accurate diagnosis of tuberculous meningitis
G-Quadruplex-Forming DNA Aptamers Inhibit the DNA-Binding Function of HupB and Mycobacterium tuberculosis Entry into Host Cells
Open AccessCharacterization of highly conserved G-quadruplex motifs as potential drug targets in Streptococcus pneumoniae
Open AccessTheranostic Application of a Novel G-Quadruplex-Forming DNA Aptamer Targeting Malate Synthase of Mycobacterium tuberculosis
Open AccessConserved G-Quadruplex Motifs in Gene Promoter Region Reveals a Novel Therapeutic Approach to Target Multi-Drug Resistance Klebsiella pneumoniae
Open AccessSmall Molecule Screening Discovers Compounds that Reduce FMRpolyG Protein Aggregates and Splicing Defect Toxicity in Fragile X-Associated Tremor/Ataxia Syndrome
Showing 1 to 8 of 24 publications